JP2019099577A - Selective antibacterial member suppressing increase of bad bacteria and selective antibacterial product using the member - Google Patents
Selective antibacterial member suppressing increase of bad bacteria and selective antibacterial product using the member Download PDFInfo
- Publication number
- JP2019099577A JP2019099577A JP2018226260A JP2018226260A JP2019099577A JP 2019099577 A JP2019099577 A JP 2019099577A JP 2018226260 A JP2018226260 A JP 2018226260A JP 2018226260 A JP2018226260 A JP 2018226260A JP 2019099577 A JP2019099577 A JP 2019099577A
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- carboxyl group
- type carboxyl
- antibacterial
- selective antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical Or Physical Treatment Of Fibers (AREA)
- Socks And Pantyhose (AREA)
- Gloves (AREA)
- Bedding Items (AREA)
- Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
【課題】抗菌素材の利用分野は化粧品、フェイスマスク、肌着、寝具等多岐にわたる。しかし、抗菌剤は皮膚感染症や食中毒を引き起こす黄色ブドウ球菌などの悪玉菌だけでなく、肌を健康に保つ表皮ブドウ球菌などの善玉菌も排除してしまう。このため、常在菌のうち悪玉菌の働きを抑え、善玉菌に対しては無毒のものが求められるが、従来の技術ではそれが困難であった。本発明は、かかる従来技術の現状に鑑みて創案されたものであり、その目的は、肌の常在菌のうち悪玉菌の増殖を抑える選択的抗菌用製品を提供することにある。【解決手段】H型カルボキシル基を有する素材を含有する部材において、H型カルボキシル基の量が0.2〜3.0mmol/gであり、かつ、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量が0.5mmol/g未満であることを特徴とする悪玉菌の増殖を抑える選択的抗菌用部材。【選択図】なしPROBLEM TO BE SOLVED: To use antibacterial materials in various fields such as cosmetics, face masks, underwear, and bedding. However, antibacterial agents eliminate not only bad bacteria such as Staphylococcus aureus that cause skin infections and food poisoning, but also good bacteria such as Staphylococcus epidermidis that keeps the skin healthy. For this reason, it is necessary to suppress the action of bad bacteria among the indigenous bacteria and to be non-toxic to good bacteria, which was difficult with the conventional techniques. The present invention was created in view of the current state of the art, and an object thereof is to provide a selective antibacterial product that suppresses the growth of bad bacteria among the indigenous bacteria of the skin. SOLUTION: In a member containing a material having an H-type carboxyl group, the amount of H-type carboxyl group is 0.2 to 3.0 mmol/g, and a salt having a divalent or higher valent metal ion as a counter ion. A selective antibacterial member for suppressing the growth of bad bacteria, characterized in that the amount of type carboxyl groups is less than 0.5 mmol/g. [Selection diagram] None
Description
本発明は、悪玉菌の増殖を抑える選択的抗菌用製品に関する。 The present invention relates to a selective anti-microbial product that reduces the growth of bad bacteria.
近年健康志向の高まりから抗菌に対する素材の開発が求められており、その分野としては化粧品、フェイスマスク、肌着、寝具等多岐にわたる。 BACKGROUND ART In recent years, development of materials for antibacterial agents has been required due to rising of health consciousness, and the fields include cosmetics, face masks, underwear, bedding, etc.
しかしながら、抗菌剤は皮膚刺激性等の影響が指摘されており(非特許文献1)、化粧品、フェイスマスク、肌着、寝具等、皮膚に接触する用途における使用では特に懸念される。また、こうした抗菌剤は肌の常在菌のうち、悪玉菌の代表であり、皮膚感染症や食中毒を引き起こす黄色ブドウ球菌やマラセチア菌を排除するのには役立つが、同時に肌を健康に保つ表皮ブドウ球菌やアクネ菌等の善玉菌も排除してしまうので、この点においても肌に悪い影響を及ぼす。 However, the antimicrobial agent is pointed out such as skin irritation (Non-Patent Document 1), and is particularly concerned with use in applications that contact the skin, such as cosmetics, face masks, underwear, and bedding. In addition, these antibacterial agents are representative of bad bacteria among the indigenous bacteria of the skin and help eliminate S. aureus and Malassezia bacteria that cause skin infections and food poisoning, but also keep the skin healthy Since good bacteria such as staphylococci and acne bacteria are also excluded, this also has an adverse effect on the skin.
上述したように、抗菌剤は菌を排除する効果は有するが菌の選択性は有さないため、有用な菌まで排除してしまうという欠点があった。こうしたことは皮膚に接触する用途では特に懸念されるところであり、常在菌のうち悪玉菌の働きを抑え、善玉菌に対しては無毒のものが求められるが、従来の技術ではそれが困難であった。本発明は、かかる従来技術の現状に鑑みて創案されたものであり、その目的は、肌の常在菌のうち悪玉菌の増殖を抑える選択的抗菌用製品を提供することにある。 As described above, since the antibacterial agent has an effect of eliminating bacteria but does not have selectivity of bacteria, there is a disadvantage that even useful bacteria are eliminated. This is a particular concern in applications that come in contact with the skin, and among the indigenous bacteria, the function of the bad bacteria is suppressed, and non-toxic products are required for good bacteria, but it is difficult with conventional techniques. there were. The present invention has been made in view of the current state of the prior art, and an object thereof is to provide a selective antibacterial product which suppresses the growth of bad bacteria among skin-resident bacteria.
本発明者は、上述の目的を達成するために鋭意検討を進めた結果、H型カルボキシル基を有する部材において、該部材中のH型カルボキシル基量を0.2〜3.0mmol/gの範囲に調整するとともに、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量を0.5mmol/g未満とすることにより、肌の常在菌のうち悪玉菌のみの増殖を抑える選択的抗菌用製品となることを見出し、本発明に到達した。 As a result of intensive studies to achieve the above-mentioned purpose, the inventor of the present invention has found that in a member having an H-type carboxyl group, the amount of H-type carboxyl group in the member is in the range of 0.2 to 3.0 mmol / g. By controlling the amount of salt type carboxyl group whose counter ion is a metal ion having a valence of 2 or more as less than 0.5 mmol / g, it is possible to selectively suppress the growth of only the bad bacteria among the indigenous bacteria of the skin. The inventors have found that the product is an antibacterial product and reached the present invention.
即ち、本発明は以下の手段により達成される。
(1)H型カルボキシル基を有する素材を含有する部材において、H型カルボキシル基の量が0.2〜3.0mmol/gであり、かつ、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量が0.5mmol/g未満であることを特徴とする悪玉菌の増殖を抑える選択的抗菌用部材。
(2)H型カルボキシル基を有する素材が繊維状であることを特徴とする(1)に記載の選択的抗菌用部材。
(3)(1)または(2)に記載の選択的抗菌用部材を皮膚に接触する部分に含有している選択的抗菌用製品。
(4)肌着、靴下、手袋、寝具の側地、フェイスマスク、化粧用コットンまたはウェットティッシュであることを特徴とする(3)に記載の選択的抗菌用製品。
That is, the present invention is achieved by the following means.
(1) A member containing a material having an H-type carboxyl group, wherein the amount of the H-type carboxyl group is 0.2 to 3.0 mmol / g, and a salt type wherein a divalent or higher metal ion is used as a counter ion A member for selective antibacterial which suppresses the growth of bad bacteria, characterized in that the amount of carboxyl group is less than 0.5 mmol / g.
(2) The selective antibacterial member according to (1), wherein the material having an H-type carboxyl group is fibrous.
(3) A product for selective antibacterial which contains the member for selective antibacterial as described in (1) or (2) in the part which contacts skin.
(4) The selective antibacterial product according to (3), which is an underwear, a sock, a glove, a side of a bedding, a face mask, a cosmetic cotton or a wet tissue.
本発明の特筆すべき効果は、製品の皮膚に接触する部分に、H型カルボキシル基量が0.2〜3.0mmol/gであり、かつ、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量が0.5mmol/g未満である部材を用いることで、肌の常在菌のうち悪玉菌の増殖を抑える選択的抗菌用製品となることを見出した点である。かかる本発明の選択的抗菌用製品は善玉菌を温存しつつ、悪玉菌の増殖を選択的に抑えることができるため、肌を健康に保つことができ、肌着、寝具の側地、フェイスマスクなどの皮膚に接触する製品として好適に利用できるものである。 A notable effect of the present invention is a salt having an amount of H-type carboxyl group of 0.2 to 3.0 mmol / g and a divalent or higher metal ion as a counter ion in the skin contacting part of the product. By using a member having a type carboxyl group content of less than 0.5 mmol / g, it has been found out that the product becomes a selective antibacterial product that suppresses the growth of bad bacteria among the resident bacteria of the skin. Such a selective antibacterial product of the present invention can selectively suppress the growth of bad bacteria while preserving good bacteria, so that the skin can be kept healthy, and underwear, bedding, face masks, etc. It can be suitably used as a product that contacts the skin of
本発明は、H型カルボキシル基を有する素材を含有する部材において、H型カルボキシル基量が0.2〜3.0mmol/gであり、かつ、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量が0.5mmol/g未満であることを特徴とする悪玉菌の増殖を抑える選択的抗菌用部材である。 The present invention provides a member containing a material having an H-type carboxyl group, wherein the amount of H-type carboxyl group is 0.2 to 3.0 mmol / g, and a salt type wherein a divalent or higher metal ion is used as a counter ion It is a member for selective antibacterial which suppresses the growth of the bad bacteria characterized by the quantity of a carboxyl group being less than 0.5 mmol / g.
まず、本発明に採用するH型カルボキシル基を有する素材は、該官能基を有していれば制限されるものではなく、低分子状から高分子状のものまで使用できる。また、その形状としては、液体状、固体状(例えば、繊維状、粒子状、塗膜状、フィルム状等)があり制限されるもので無く、どれを選択するかは加工性、耐久性、用途等を加味して選択できる。 First, the material having an H-type carboxyl group employed in the present invention is not limited as long as it has the functional group, and low molecular to high molecular materials can be used. Further, the shape thereof is not limited as it is liquid or solid (for example, fibrous, particulate, coating, film, etc.), and is not limited, and which one is selected is processability, durability, It can be selected in consideration of applications and the like.
かかるH型カルボキシル基を有する素材のうち、低分子状の素材としては、酢酸、酪酸、酒石酸、クエン酸、シュウ酸、安息香酸等が挙げられる。 Among the materials having the H-type carboxyl group, examples of low molecular weight materials include acetic acid, butyric acid, tartaric acid, citric acid, oxalic acid, benzoic acid and the like.
また、高分子状の素材としては、ポリアクリル酸、ポリメタクリル酸、ポリマレイン酸及びアクリル酸、メタクリル酸、マレイン酸の共重合ポリマー等が挙げられる。 Moreover, as a polymeric material, a copolymer of polyacrylic acid, polymethacrylic acid, polymaleic acid and acrylic acid, methacrylic acid and maleic acid, and the like can be mentioned.
繊維状の素材としては、ヒドラジン等の架橋剤による架橋導入処理とアルカリ性化合物による加水分解処理を施して得られる架橋アクリレート系繊維を酸処理して得られる繊維や特開2013−147774に記載された方法で得ることができる繊維などがある。繊維状の素材は、耐久性や風合いが重視される肌着、寝具の側地等に用いられる本発明の選択的抗菌用部材に好適に利用できる。 As a fibrous material, a fiber obtained by acid treatment of a crosslinked acrylate fiber obtained by subjecting a crosslinking introduction treatment with a crosslinking agent such as hydrazine and a hydrolysis treatment with an alkaline compound or the like is described in JP-A 2013-147774 There are fibers that can be obtained by the method. The fibrous material can be suitably used for the selective antibacterial member of the present invention which is used for underwear, which places importance on durability and feeling, side of bedding, and the like.
上述の架橋アクリレート系繊維としては、例えば特開2000−314082号公報に記載のように、アクリロニトリル含有率が85〜95重量%であるアクリル系繊維に対するヒドラジン系化合物による架橋処理によって導入される窒素含有量の増加が、1.0〜5.0重量%である架橋アクリレート系繊維であって、残存ニトリル基の一部が加水分解処理により3.0〜6.0meq/gのアルカリ金属塩型カルボキシル基に変換されている繊維が挙げられる。このような架橋アクリレート系繊維を硝酸水溶液に浸漬するなどして塩型カルボキシル基をH型カルボキシル基に変換したものを本発明におけるH型カルボキシル基を有する繊維状の素材として採用することができる。なお、H型カルボキシル基の量は加水分解処理における薬剤濃度、反応時間、反応温度などを変化させることによって調整することができる。 As the above-mentioned crosslinked acrylate fiber, for example, as described in JP-A-2000-314082, a nitrogen-containing compound introduced by crosslinking treatment of an acrylic fiber having an acrylonitrile content of 85 to 95% by weight with a hydrazine compound A cross-linked acrylate fiber having an increase in the amount of 1.0 to 5.0% by weight, wherein a part of the remaining nitrile group is hydrolyzed to 3.0 to 6.0 meq / g of alkali metal salt type carboxyl group Fibers that have been converted into groups are mentioned. What converted the salt type carboxyl group into the H type carboxyl group by immersing such a crosslinked acrylate type fiber in nitric acid aqueous solution etc. can be employ | adopted as a fibrous material which has the H type carboxyl group in this invention. The amount of H-type carboxyl group can be adjusted by changing the drug concentration, reaction time, reaction temperature and the like in the hydrolysis treatment.
また、粒子状の素材としては、陽イオン交換樹脂や特開2013−147473号公報に記載された方法で製造できるH型カルボキシル基を有する架橋粒子などが挙げられる。 Moreover, as a particulate-form raw material, the crosslinked particle etc. which have a H type carboxyl group which can be manufactured by the method described in the cation exchange resin and Unexamined-Japanese-Patent No. 2013-147473 etc. are mentioned.
本発明に言う悪玉菌とは、増殖により肌の炎症や肌荒れを引き起こす菌のことで黄色ブドウ球菌やマラセチア菌、白癬菌、カンジダ菌等が該当するが、この中でも黄色ブドウ球菌が特に問題となることが多い。また、善玉菌とは肌の乾燥を防ぎ外部刺激から守る働きをする菌のことで表皮ブドウ球菌、アクネ菌等が該当する。 The bad bacteria referred to in the present invention are bacteria which cause inflammation and roughening of the skin by proliferation, and include Staphylococcus aureus, Malassezia bacteria, Trichophyton bacteria, Candida bacteria etc., among which Staphylococcus aureus is particularly problematic. There are many things. Also, good bacteria are bacteria that work to prevent skin dryness and protect from external stimuli, and epidermidis staphylococci, acne bacteria, etc. are applicable.
本発明の選択的抗菌用部材は、H型カルボキシル基量として0.2〜3.0mmol/g、好ましくは0.5〜2.0mmol/g有するようになるように、上述したH型カルボキシル基を有する素材を含有させたものである。H型カルボキシル基量が0.2mmol/gに満たない場合、悪玉菌の増殖を抑えることが難しくなり、逆に、3.0mmol/gを超える場合には、悪玉菌だけでなく、善玉菌の増殖も抑えてしまうこととなる。 The member for selective antibacterial of the present invention has the H-type carboxyl group described above so as to have an amount of H-type carboxyl group of 0.2 to 3.0 mmol / g, preferably 0.5 to 2.0 mmol / g. Containing the material having When the amount of H-type carboxyl group is less than 0.2 mmol / g, it is difficult to suppress the growth of bad bacteria, and conversely, when it exceeds 3.0 mmol / g, not only bad bacteria but also good bacteria It will also reduce proliferation.
H型カルボキシル基を上記範囲とすることによって、悪玉菌の増殖を選択的に抑えることができる理由は定かではないが、悪玉菌と善玉菌は増殖に好適な環境が異なっており、悪玉菌はH型カルボキシル基に対する耐性が弱い、又は該官能基の存在で増殖が抑制されやすい可能性がある。 It is not clear why the growth of bad bacteria can be selectively suppressed by setting the H-type carboxyl group to the above range, but bad bacteria and good bacteria have different environments suitable for growth, and bad bacteria The resistance to the H-type carboxyl group may be weak, or the presence of the functional group may easily suppress the growth.
また、本発明の選択的抗菌用部材においては、塩型カルボキシル基量をできるだけ少なくすることが望ましい。特に、2価以上の金属イオンを対イオンとする塩型カルボキシル基の量を0.5mmol/g未満とすることが肝要である。2価金属イオンの塩型カルボキシル基量が0.5mmol/gを超えると、善玉菌であるアクネ菌の増殖できなくなる。また、1価の金属イオンを対イオンとする塩型カルボキシル基についても、2価金属イオンの塩型カルボキシル基ほどではないが善玉菌の増殖を抑制する効果があるため、その含有量を2.0mmol/g以下とすることが好ましく、1.0mmol/g以下とすることがより好ましい。 Further, in the selective antibacterial member of the present invention, it is desirable to reduce the amount of salt type carboxyl group as much as possible. In particular, it is important that the amount of the salt type carboxyl group whose counter ion is a divalent or higher metal ion be less than 0.5 mmol / g. When the amount of salt type carboxyl group of the divalent metal ion exceeds 0.5 mmol / g, it is not possible to grow good bacteria such as acne bacteria. In addition, the salt type carboxyl group having a monovalent metal ion as a counter ion also has the effect of suppressing the growth of a good bacteria, although not to the extent of the salt type carboxyl group of the divalent metal ion. It is preferably 0 mmol / g or less, more preferably 1.0 mmol / g or less.
本発明の選択的抗菌用部材としては、フィルム、塗膜、ビーズ、射出成形体等の樹脂成形体や、糸、ヤーン(ラップヤーンも含む)、フィラメント、織物、編物、不織布、紙状物、シート状物、積層体、綿状体(球状や塊状のものを含む)等の繊維構造物などを挙げることができる。また、かかる本発明の選択的抗菌用部材は、上記したH型カルボキシル基量を満たす限りであれば、H型カルボキシル基を有する素材単独で構成されていてもよいし、他の素材と組み合わせたものであってもよい。 The member for selective antimicrobial of the present invention is a resin molding such as a film, a coating, a bead, an injection molded body, a yarn, a yarn (including a wrap yarn), a filament, a woven fabric, a knitted fabric, a non-woven fabric, a paper-like material, Examples thereof include sheet-like materials, laminates, and fibrous structures such as cotton-like materials (including spherical and massive materials). In addition, the selective antibacterial member of the present invention may be constituted of a material having an H-type carboxyl group alone, as long as it satisfies the above-mentioned H-type carboxyl group weight, or it is combined with other materials It may be one.
具体的な例としては、液体状あるいは溶剤に溶解して溶液状としたH型カルボキシル基を有する素材をフィルムや生地に塗布して得られるシートや、繊維状のH型カルボキシル基を有する素材を、他の繊維状素材と混用した糸、編織物、不織布などの繊維構造物を挙げることが出来る。 As a specific example, a sheet obtained by applying a material having an H-type carboxyl group dissolved in a liquid or solvent to a solution form to a film or a fabric, or a material having a fibrous H-type carboxyl group And fiber structures such as yarn mixed with other fibrous materials, knitted fabric, non-woven fabric and the like.
上記の繊維構造物において併用しうる他の繊維状素材としては特に制限はなく、公用されている天然繊維、有機繊維、半合成繊維、合成繊維が用いられ、さらには無機繊維、ガラス繊維等も用途によっては採用し得る。具体的な例としては、綿、麻、絹、羊毛、ナイロン、レーヨン、ポリエステル、アクリル繊維などを挙げることができる。 There is no particular limitation on other fibrous materials that can be used together in the above fiber structure, and commonly used natural fibers, organic fibers, semi-synthetic fibers, synthetic fibers are used, and inorganic fibers, glass fibers, etc. are also used. It may be adopted depending on the application. Specific examples include cotton, hemp, silk, wool, nylon, rayon, polyester, acrylic fiber and the like.
また、本発明の選択的抗菌用製品は、上述した本発明の選択的抗菌用部材を製品の表層部などの皮膚に接触する部分に含有させたものである。かかる本発明の選択的抗菌用製品は、善玉菌を温存しつつ、悪玉菌の増殖を選択的に抑えることができるという効果を有するものである。このことから、皮膚に長時間あるいは広い面積で接触する製品として適している。具体的な製品としては、上述した様々な形態の本発明の選択的抗菌用部材のうちの編物を用いた肌着、靴下、手袋、織物または編物を側地に用いた寝具、不織布を顔面に接触する側に用いたフェイスマスク、化粧用コットン、不織布を用いたウェットティッシュなどが挙げられる。 Further, the selective antibacterial product of the present invention comprises the above-mentioned selective antibacterial member of the present invention in a portion in contact with the skin such as a surface layer of the product. The selective antibacterial product of the present invention has an effect of being able to selectively suppress the growth of bad bacteria while preserving good bacteria. From this, it is suitable as a product which contacts skin for a long time or a large area. Specific products include underwear, socks, gloves, woven or non-woven bedding, and non-woven fabric on the face using the knitted fabric of the selective antibacterial member of the present invention in various forms described above. Such as a face mask used on the side to be used, cotton for makeup, and a wet tissue using a non-woven fabric.
以下に本発明の理解を容易にするために実施例を示すが、これらはあくまで例示的なものであり、本発明の要旨はこれらにより限定されるものではない。なお、実施例中、部及び百分率は特に断りのない限り重量基準で示す。 Examples are given below to facilitate understanding of the present invention, but these are merely illustrative, and the scope of the present invention is not limited by these. In the examples, parts and percentages are indicated on a weight basis unless otherwise noted.
<H型カルボキシル基量、塩型カルボキシル基量の測定>
十分乾燥した試料約1gを精秤し(W1g)、これに200mlの1mol/L塩酸水溶液を加え、試料を浸漬させて、30分間放置した後、ガラスフィルターで濾過し、水を加えて水洗する。この処理を3回繰返した後、濾液のpHが5以上になるまで十分に水洗する。次にこの資料を200mlの純水に入れ、1mol/L塩酸水溶液を添加してpH2にした後、0.1mol/L水酸化ナトリウム水溶液で情報に従って滴定曲線を求める。該滴定曲線から、全カルボキシル基に消費された水酸化ナトリウム水溶液消費量(Vml)を求め、次式によって全カルボキシル基量を求める。
全カルボキシル基量(mmol/g)=(0.1×V)/W1
次に、上記の全カルボキシル基量の測定方法において、最初の1mol/L塩酸水溶液への浸漬およびそれに続く水洗を実施しないこと以外は同様にして、H型カルボキシル基量を算出する。さらに、かかるH型カルボキシル基量を上記の全カルボキシル基量から差し引くことで、塩型カルボキシル基量を算出する。
<Measurement of H-type carboxyl group content and salt-type carboxyl group content>
Approximately 1 g of a sufficiently dried sample is precisely weighed (W 1 g), 200 ml of 1 mol / L aqueous hydrochloric acid solution is added thereto, and the sample is immersed and allowed to stand for 30 minutes. . After repeating this treatment three times, the solution is thoroughly washed with water until the pH of the filtrate reaches 5 or more. Next, this material is put into 200 ml of pure water, and 1 mol / L aqueous hydrochloric acid solution is added to adjust to pH 2, and then a titration curve is determined according to the information with 0.1 mol / L aqueous sodium hydroxide solution. From the titration curve, the consumed amount (V ml) of the aqueous sodium hydroxide solution consumed for all carboxyl groups is determined, and the total amount of carboxyl groups is determined by the following equation.
Total amount of carboxyl groups (mmol / g) = (0.1 × V) / W1
Next, the amount of H-type carboxyl groups is calculated in the same manner as in the above-described method for measuring the total amount of carboxyl groups, except that the first immersion in 1 mol / L hydrochloric acid aqueous solution and the subsequent water washing are not performed. Furthermore, the amount of salt-type carboxyl groups is calculated by subtracting the amount of H-type carboxyl groups from the total amount of carboxyl groups described above.
<抗菌試験>
37℃で約20時間前培養した菌を滅菌生理食塩液に懸濁した後、OD630nmを約0.12に調整した。その後、1/2ニュートリエント培地で約100倍に希釈し、試験菌液とした。滅菌したバイアル瓶(30mL容量)にあらかじめ消毒用エタノールを十分噴霧後、安全キャビネット内で乾燥させた各供試試料(コントロールは綿繊維)0.4gをバイアル瓶の底部に添加した。試験菌液0.2mLずつを加えた後、37℃で18時間前培養した。培養直後および37℃で18時間後に、各バイアルに緩衝生理食塩液20mLを加え、30回激しく振り混ぜた(100倍)。生理食塩液で101から105倍希釈した。原液および各希釈液1mLずつをそれぞれ2枚ずつの滅菌プラスチックシャーレに加え、滅菌後約50℃に保温したニュートリエント寒天培地約20mLを加え、混釈した。冷却し、37℃で約48時間培養後、出現する菌数を計測し、下記式により菌増殖値を計算した。
菌増殖値=LOG(培養後の菌数)−LOG(培養前の菌数)
菌増殖値が正の値であれば菌が増殖していることを示し、負の値であれば菌が減少していることを示す。
<Antibacterial test>
After suspending the bacteria precultured at 37 ° C. for about 20 hours in sterile physiological saline, the OD630 nm was adjusted to about 0.12. Thereafter, it was diluted about 100 times with 1⁄2 nutrient culture medium to prepare a test solution. After sufficiently spraying ethanol for sterilization into a sterilized vial (volume of 30 mL), 0.4 g of each test sample (control: cotton fiber) dried in a safety cabinet was added to the bottom of the vial. After 0.2 mL each of the test solution was added, it was precultured at 37 ° C. for 18 hours. Immediately after incubation and after 18 hours at 37 ° C., 20 mL of buffered saline was added to each vial and shaken vigorously 30 times (100 ×). It was diluted 10 1 to 10 5 times with saline. The stock solution and 1 mL of each diluted solution were added to each of 2 pieces of sterile plastic petri dishes, and about 20 mL of nutrient agar medium kept at about 50 ° C. after sterilization was added and mixed. After cooling and culturing for about 48 hours at 37 ° C., the number of emerging bacteria was counted, and the bacterial growth value was calculated by the following equation.
Fungal growth value = LOG (number of bacteria after culture) -LOG (number of bacteria before culture)
If the bacterial growth value is a positive value, it indicates that the bacterial growth is occurring, and if it is a negative value, it indicates that the bacterial growth is decreasing.
<実施例1>
アクリロニトリル90%及びアクリル酸メチル10%からなるアクリロニトリル系重合体10部を48%のチオシアン酸ナトリウム水溶液90部に溶解した紡糸原液を用いて常法にて紡糸を行い、アクリル繊維を得た。得られたアクリル繊維を15%ヒドラジン水溶液中で110℃×3時間架橋導入処理を行い水洗した。次に、8%硝酸水溶液中で110℃×1時間酸処理を行い水洗した。続いて5%水酸化ナトリウム水溶液中で、90℃で1時間加水分解処理を行い水洗し、塩型のカルボキシル基を有する架橋アクリレート系繊維を得た。その後3%硝酸水溶液中にて110℃×1時間酸処理を行い水洗して、H型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Example 1
An acrylic fiber was obtained by spinning in the usual way using a spinning solution prepared by dissolving 10 parts of an acrylonitrile polymer consisting of 90% acrylonitrile and 10% methyl acrylate in 90 parts of a 48% aqueous sodium thiocyanate solution. The obtained acrylic fiber was subjected to a crosslinking introduction treatment in a 15% aqueous hydrazine solution at 110 ° C. for 3 hours, and washed with water. Next, it was acid-treated in an 8% nitric acid aqueous solution at 110 ° C. for 1 hour and washed with water. Subsequently, hydrolysis treatment was performed at 90 ° C. for 1 hour in a 5% aqueous sodium hydroxide solution, followed by washing with water to obtain a crosslinked acrylate fiber having a salt type carboxyl group. Thereafter, acid treatment was carried out in a 3% nitric acid aqueous solution at 110 ° C. for 1 hour, followed by washing with water to obtain a fiber having an H-type carboxyl group. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<実施例2〜5>
実施例1において水酸化ナトリウム水溶液での加水分解処理の時間を、実施例2では40分、実施例3では20分、実施例4では10分、実施例5では5分に変えた以外は同様に行いH型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Examples 2 to 5
The same procedure as Example 1 was repeated except that the time of hydrolysis treatment with an aqueous solution of sodium hydroxide was changed to 40 minutes in Example 2, 20 minutes in Example 3, 10 minutes in Example 4, and 5 minutes in Example 5. To obtain a fiber having an H-type carboxyl group. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<実施例6>
下記比較例1で得られたH型カルボキシル基を有する繊維を30%、ポリエステルを70%の割合で混合してカードウェブとし、ニードルパンチ法により目付50g/m2の不織布を作成した。得られた不織布の抗菌性能を評価した結果を表に示す。
Example 6
The fiber having H-type carboxyl group obtained in Comparative Example 1 below was mixed at a ratio of 30% and polyester at a ratio of 70% to form a carded web, and a nonwoven fabric with a fabric weight of 50 g / m 2 was formed by a needle punch method. The result of having evaluated the antimicrobial performance of the obtained nonwoven fabric is shown in a table | surface.
<実施例7>
実施例1において、水酸化ナトリウム水溶液での加水分解処理の時間を30分に変えたこと、および、3%硝酸水溶液中での酸処理の代わりに、リン酸ナトリウム緩衝液によるpH=7.0への調整処理を行うこと以外は同様にして、H型カルボキシル基とNa塩型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Example 7
In Example 1, the time of hydrolysis treatment with aqueous sodium hydroxide solution was changed to 30 minutes, and instead of acid treatment in aqueous 3% nitric acid solution, pH = 7.0 with sodium phosphate buffer solution A fiber having an H-type carboxyl group and a Na salt-type carboxyl group was obtained in the same manner except that the adjustment treatment to The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<実施例8>
実施例1において、8%硝酸水溶液中での酸処理後の水洗までは同様に行い、続いて5%水酸化ナトリウム水溶液中で、90℃で15分間加水分解処理を行い水洗し、次に5%硫酸マグネシウム水溶液中で80℃×1時間処理を行い水洗した。得られた繊維を純水中に加え、3%硝酸水溶液を加えることでpH5.0に調整することにより、H型カルボキシル基とMg塩型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Example 8
In Example 1, the same procedure is followed until water washing after acid treatment in 8% nitric acid aqueous solution, followed by hydrolysis treatment in 5% sodium hydroxide aqueous solution at 90 ° C. for 15 minutes, and then water washing, then 5 % Aqueous solution of magnesium sulfate and treated with water for 1 hour at 80.degree. The obtained fiber was added to pure water, and adjusted to pH 5.0 by adding a 3% nitric acid aqueous solution to obtain a fiber having an H-type carboxyl group and an Mg salt-type carboxyl group. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<実施例9>
実施例8において、5%硫酸マグネシウム水溶液の代わりに5%硫酸カルシウム水溶液を用いること以外は同様にして、H型カルボキシル基とCa塩型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Example 9
A fiber having an H-type carboxyl group and a Ca salt-type carboxyl group was obtained in the same manner as in Example 8 except that a 5% aqueous solution of calcium sulfate was used instead of the 5% aqueous solution of magnesium sulfate. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<比較例1>
実施例1において、水酸化ナトリウム水溶液での加水分解処理の時間を70分に変えたこと以外は同様に行いH型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 1
A fiber having an H-type carboxyl group was obtained in the same manner as in Example 1 except that the time of hydrolysis treatment with an aqueous sodium hydroxide solution was changed to 70 minutes. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<比較例2>
実施例1において、水酸化ナトリウム水溶液での加水分解処理の時間を1分に変えたこと以外は同様に行いH型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 2
A fiber having an H-type carboxyl group was obtained in the same manner as in Example 1 except that the time of hydrolysis treatment with an aqueous solution of sodium hydroxide was changed to 1 minute. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<比較例3>
実施例1で得られた原料のアクリル繊維に4級アンモニウム抗菌剤を0.2重量%付与して得られた繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 3
The result of having evaluated the antimicrobial performance of the fiber obtained by giving 0.2 weight% of quaternary ammonium antimicrobial agents to the acrylic fiber of the raw material obtained in Example 1 is shown in a table | surface.
<比較例4>
実施例1で得られた原料のアクリル繊維に硝酸銀水溶液に浸漬し、加熱乾燥させることによって、銀を0.2重量%付与した繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 4
The results obtained by evaluating the antibacterial performance of the fiber to which 0.2% by weight of silver was imparted by immersing the acrylic fiber of the raw material obtained in Example 1 in an aqueous solution of silver nitrate and drying by heating are shown in the table.
<比較例5>
実施例1において、8%硝酸水溶液中での酸処理後の水洗までは同様に行い、続いて5%水酸化ナトリウム水溶液中で、90℃で30分間加水分解処理を行い水洗し、次に5%硫酸マグネシウム水溶液中で80℃×1時間処理を行い水洗した。得られた繊維を純水中に加え、3%硝酸水溶液を加えることでpH7.0に調整することにより、H型カルボキシル基とMg塩型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 5
In Example 1, the same procedure is followed until water washing after acid treatment in an 8% nitric acid aqueous solution, followed by hydrolysis treatment in a 5% aqueous sodium hydroxide solution at 90 ° C. for 30 minutes, and then water washing, then 5 % Aqueous solution of magnesium sulfate and treated with water for 1 hour at 80.degree. The obtained fiber was added to pure water, and adjusted to pH 7.0 by adding a 3% nitric acid aqueous solution to obtain a fiber having an H-type carboxyl group and an Mg salt-type carboxyl group. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
<比較例6>
比較例5において、5%硫酸マグネシウム水溶液の代わりに5%硫酸カルシウム水溶液を用いること以外は同様にして、H型カルボキシル基とCa塩型カルボキシル基を有する繊維を得た。得られた繊維の抗菌性能を評価した結果を表に示す。
Comparative Example 6
A fiber having an H-type carboxyl group and a Ca salt-type carboxyl group was obtained in the same manner as in Comparative Example 5 except that a 5% aqueous solution of calcium sulfate was used instead of the 5% aqueous solution of magnesium sulfate. The results of evaluating the antibacterial performance of the obtained fiber are shown in the table.
本発明に特定するH型カルボキシル基量を有する実施例1〜5の繊維では善玉菌の数の減少は見られず、悪玉菌のみを選択的に減少させることが出来ている。また、実施例6の部材は、比較例1の繊維を含有する部材であるが、部材としてのH型カルボキシル基量が本発明に特定する範囲内となっているため、悪玉菌のみを選択的に減少させることが出来ている。 In the fibers of Examples 1 to 5 having the amount of H-type carboxyl group specified in the present invention, no decrease in the number of good bacteria is observed, and only bad bacteria can be selectively reduced. Moreover, although the member of Example 6 is a member containing the fiber of Comparative Example 1, since the amount of H-type carboxyl group as a member is within the range specified in the present invention, only the bad bacteria are selectively selected. Can be reduced to
さらに、実施例7〜9の繊維についても悪玉菌のみを選択的に減少させることが出来ている。ただし、実施例7〜9の繊維は塩型カルボキシル基を有しているため、同等のH型カルボキシル基を有する実施例4の部材と比べて、善玉菌の増殖値が少なくなり、悪玉菌の減少効果も小さくなっている。 Furthermore, only the bad bacteria were able to be selectively reduced also about the fiber of Examples 7-9. However, since the fibers of Examples 7 to 9 have a salt type carboxyl group, the growth value of good bacteria is reduced compared to the member of Example 4 having an equivalent H-type carboxyl group, and The reduction effect is also smaller.
一方、H型カルボキシル基が本発明より多い比較例1の部材では善玉菌の増殖が抑制され、H型カルボキシル基が本発明より少ない比較例2の部材では悪玉菌の増殖の抑制が出来ていないことが分かる。また、比較例3の4級アンモニウム抗菌剤を付与した繊維や比較例4の銀系の抗菌剤を付与した繊維は悪玉菌よりも、善玉菌の減少が大きくなっており、これら比較例の素材は肌に悪い影響を与えることが分かる。さらに、比較例5および6の部材においては、2価金属イオンを対イオンとする塩型カルボキシル基を多く有するため、善玉菌であるアクネ菌が減少する結果となっている。 On the other hand, in the member of Comparative Example 1 having more H-type carboxyl groups than the present invention, the growth of good bacteria is suppressed, and in the member of Comparative Example 2 having less H-type carboxyl groups than the present invention, the growth of bad bacteria can not be suppressed. I understand that. In addition, the fiber to which the quaternary ammonium antibacterial agent of Comparative Example 3 is added and the fiber to which the silver-based antibacterial agent of Comparative Example 4 is applied are more reduced in good bacteria than bad bacteria, and the materials of these Comparative Examples Is found to adversely affect the skin. Furthermore, in the members of Comparative Examples 5 and 6, since many salt type carboxyl groups having a divalent metal ion as a counter ion are contained, it is a result that acne bacteria which are good bacteria are decreased.
Claims (4)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017234876 | 2017-12-07 | ||
| JP2017234876 | 2017-12-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019099577A true JP2019099577A (en) | 2019-06-24 |
| JP7298142B2 JP7298142B2 (en) | 2023-06-27 |
Family
ID=66975926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018226260A Active JP7298142B2 (en) | 2017-12-07 | 2018-12-03 | Selective antibacterial fiber structure that reduces Staphylococcus aureus without reducing P. acnes and Staphylococcus epidermidis and antibacterial product containing the fiber structure |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7298142B2 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000064149A (en) * | 1998-08-18 | 2000-02-29 | Japan Exlan Co Ltd | Composition containing fibers that prevent sweat odor and body odor |
| WO2005007714A1 (en) * | 2003-07-18 | 2005-01-27 | Japan Exlan Company Limited | Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| KR20070005658A (en) * | 2004-03-02 | 2007-01-10 | 닛폰 에쿠스란 고교 가부시키가이샤 | Antiviral fibers, and methods of making the fibers, and fiber products using the fibers |
| JP2009013557A (en) * | 2007-06-08 | 2009-01-22 | Toyobo Co Ltd | Cloth products with little cold feeling after moisture absorption |
| JP2014074243A (en) * | 2012-10-03 | 2014-04-24 | Japan Exlan Co Ltd | Photocatalyst inclusion fiber and fiber structure including the fiber |
-
2018
- 2018-12-03 JP JP2018226260A patent/JP7298142B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000064149A (en) * | 1998-08-18 | 2000-02-29 | Japan Exlan Co Ltd | Composition containing fibers that prevent sweat odor and body odor |
| WO2005007714A1 (en) * | 2003-07-18 | 2005-01-27 | Japan Exlan Company Limited | Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| KR20070005658A (en) * | 2004-03-02 | 2007-01-10 | 닛폰 에쿠스란 고교 가부시키가이샤 | Antiviral fibers, and methods of making the fibers, and fiber products using the fibers |
| JP2009013557A (en) * | 2007-06-08 | 2009-01-22 | Toyobo Co Ltd | Cloth products with little cold feeling after moisture absorption |
| JP2014074243A (en) * | 2012-10-03 | 2014-04-24 | Japan Exlan Co Ltd | Photocatalyst inclusion fiber and fiber structure including the fiber |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7298142B2 (en) | 2023-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6612375B6 (en) | Disinfecting compositions for fabrics and related substrates, and to provide antibacterial, antiviral, and antifungal disinfection, wash durability, and enhance as needed with multifunctional properties Substrate processing method | |
| US7629000B2 (en) | Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby | |
| JP6608365B2 (en) | Cellulose fiber | |
| GB2370226A (en) | Wound dressing | |
| CA2789871A1 (en) | Low ph, optimal orp, and odor-reducing fibers, a process for making the fibers, and articles made therefrom | |
| WO2016206638A1 (en) | Wound dressing containing silver chelate fiber | |
| CN103835124A (en) | Silver-carried cotton fabric antibacterial material and preparation method thereof | |
| US20230096579A1 (en) | Antiseptic wound dressing | |
| Üreyen et al. | Antibacterial functionalization of cotton and polyester fabrics with a finishing agent based on silver-doped calcium phosphate powders | |
| CN108621481B (en) | Antibacterial fabric containing silver ions and antibacterial textile | |
| WO2001092632A1 (en) | Fiber product having antibacterial and deodorant function | |
| EP2756846A1 (en) | Antimicrobial cellulose material and process of its production | |
| Goldade et al. | Antimicrobial fibers for textile clothing and medicine: current state | |
| RU2402655C2 (en) | Method for production of antimicrobial silver-containing fibre based on natural polymer | |
| JP2011127243A (en) | Bacteriostatically treating method | |
| CN108004762A (en) | One kind is with Nanometer Copper anti bacteria natural silk product and preparation method thereof | |
| JP2019099577A (en) | Selective antibacterial member suppressing increase of bad bacteria and selective antibacterial product using the member | |
| US9924714B2 (en) | Impregnatable matrix of plant, animal or synthetic origin or mixtures of same, containing a uniformly distributed antimicrobial compound, method for impregnating said matrix with a compound, and use thereof in the production of antimicrobial elements | |
| JP4826382B2 (en) | Antibacterial cellulose fiber and textile product for skin contact | |
| CN107964785B (en) | Antibacterial silk product loaded with nanometer copper and preparation method thereof | |
| JP2017197853A (en) | Antibacterial fiber and method for producing the same | |
| CN110331573A (en) | A kind of preparation method of the antibiotic fabric based on gamma-ray irradiation crosslinking technology | |
| JPH02307915A (en) | Antibacterial fiber product | |
| TW201215717A (en) | Method for preparing superabsorbent antibacterial fiber | |
| EP4029982B1 (en) | Process for treating yarn, knit or fabric with an antimicrobial agent of non-release type |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220712 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220901 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230214 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230516 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230529 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7298142 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |